Discover 1,134 paid clinical trials in Norwalk, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,134
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Valhalla NY, New Haven CT, The Bronx NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
StrokeNet Thrombectomy Endovascular Platform
for
Ischemic Stroke
Location: Stony Brook NY, New Haven CT, The Bronx NY, New York NY,
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT06289985
Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Stony Brook NY, New Haven CT, New York NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05735184
Phase 1, Recruiting
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
for
Peripartum Cardiomyopathy, Postpartum
Location: Stony Brook NY, New Haven CT, The Bronx NY, New York NY,
Sponsor: Dennis M. McNamara, MD, MS
Sex: Female
Age: 18+
Code: NCT05180773
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
for
Type B Aortic Dissection
Location: Stony Brook NY, Roslyn NY, New Haven CT, New York NY,
Sponsor: Duke University
Sex: All
Age: 21+
Code: NCT06087029
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The ArtixASCEND Study
for
Acute Lower Limb Arterial Occlusion
Location: Stony Brook NY, New Haven CT, New York NY, Brooklyn NY,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT07135895
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Stony Brook NY, Mineola NY, The Bronx NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Location: Derby CT, New Haven CT, North Haven CT, Guilford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06465316
Phase 1, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Derby CT, New Haven CT, Guilford CT, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase 2, Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn Disease
Location: Carmel NY, Hamden CT, New York NY, New Bedford MA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07499232
Phase 3, Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Port Jefferson Station NY, New Haven CT, The Bronx NY,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase 3, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration